Volume 25, Issue 1 - Authors and Authorship

Ghostwriting prevalence among AMWA and EMWA members (2005 to 2014)

Authors: Cindy W. Hamilton, Adam Jacobs

Abstract

Download the full article

References

1. Rennie D, Flanagin A. Authorship! Authorship! Guests, ghosts, grafters, and the two-sided coin. JAMA. 1994;271(6):469-471.
2. Sharp D. A ghostly crew. Lancet. 1998;351(9109):1076.
3. Smith R. Beyond conflict of interest. Transparency is the key. BMJ. 1998;317(7154):291-292.
4. Lanier WL. Bidirectional conflicts of interest involving industry and medical journals: who will champion integrity? Mayo Clin Proc. 2009;84(9):771-775.
5. Foote MA, Hamilton C, Royer MG. Contributions of medical writers to scientific publications. AMWA J. 2002;17(4):48.
6. Jacobs A, Wager E. European Medical Writers Association (EMWA) guidelines on the role of medical writers in developing peer-reviewed publications. Curr Med Res Opin. 2005;21(2):317-321.
7. Battisti WP, Wager E, Baltzer L, et al. Good Publication Practice for Communicating Company-Sponsored Medical Research: GPP3. Ann Intern Med. 2015:epub ahead of print.
8. Huth EJ, Case K. The URM: twentyfive years old. Science Editor. 2004;27(1):17-21.
9. International Committee of Medical Journal Editors. Uniform Requirements for Manuscripts Submitted to Biomedical Journals: writing and editing for biomedical publication. 2006. Available from: http://www.icmje.org/recommendations/archives/2006_urm.pdf
10. International Committee of Medical Journal Editors. Uniform Requirements for Manuscripts Submitted to Biomedical Journals: writing and editing for biomedical publication. 2007. Available from: http://www.icmje.org/recommendations/archives/2007_urm.pdf
11. International Committee of Medical Journal Editors. Uniform Requirements for Manuscripts Submitted to Biomedical Journals: writing and editing for biomedical publication. 2008. Available from: http://www.icmje.org/recommendations/archives/2008_urm.pdf
12. International Committee of Medical Journal Editors. Uniform requirements for manuscripts submitted to biomedical journals: writing and editing for biomedical publication. 2014. Available from: http://www.icmje.org/index.html
13. Pharmaceutical Research and Manufacturers of America. Principles on conduct of clinical trials and communication of clinical trial results. 2014. Available from: http://phrma.org/sites/default/files/pdf/042009_clinical_trial_principles_final_0.pdf
14. Royer MG, Hamilton CW. The story behind the AMWA Task Force on the Contribution of Medical Writers to Scientific Publications. AMWA J. 2002;17(3):5-6.
15. Hamilton CW, Royer MG. AMWA Position Statement on the Contributions of Medical Writers to Scientific Pub lic - ations. AMWA J. 2003;18(1):13-15.
16. Stretton S. Systematic review on the primary and secondary reporting of the prevalence of ghostwriting in the medical literature. BMJ Open. 2014;4(7):e004777.
17. Hamilton CW, Jacobs A. Survey of AMWA and EMWA members who make substantial contributions to manuscripts (abstract 3). AMWA Journal. 2006;21(2):50.
18. Jacobs A, Hamilton CW. Decreased evidence of ghostwriting in a 2008 vs 2005 survey of medical writers. Write Stuff. 2009;18(2):118-123.
19. Hamilton CW, Jacobs A. Evidence of decreased ghostwriting in a series of three surveys of medical communicators conducted between 2005 and 2011 (abstract). AMWA J. 2011;27(3):115.
20. Hamilton C, Peña T, Platt M, Gertel A. Transforming perceptions of medical writers from coal to diamonds – If Superman can do it, so can we! (open session 24). American Medical Writers Association Annual Conference. San Antonio, TX; 2015.
21. Graf C, Battisti WP, Bridges D, et al. Research Methods & Reporting. Good publication practice for communicating company sponsored medical research: the GPP2 guidelines. BMJ. 2009;339:b4330.
22. Hamilton CW, Hudson S, Gegeny T. AMWA Code of Ethics added to membership application and renewal forms. AMWA J. 2008;23(4):177-179.
23. Marušić A, Hren D, Mansi B, et al. Five-step authorship framework to improve transparency in disclosing contributors to industry-sponsored clinical trial publications. BMC Med. 2014;12:197-206.
24. Wager E, Woolley K, Adshead V, et al. Awareness and enforcement of guidelines for publishing industrysponsored medical research among publication professionals: the Global Publication Survey. BMJ Open. 2014;4(4):e004780.
25. Woolley KL, Dickson T, Seth A, Stretton S. The Certified Medical Publication Professional (CMPP) credential: more than a knowledge test? (poster 30). 11th Annual Meeting of the International Society for Medical Publication Professionals. Arlington, VA; 2015.
26. Woolley KL, Feeny S, Ralston J, Marchington J, Palmisano SM, McMurray B. For the greater good... Can agency competitors cooperate to advance medical publication practices? Med Writing. 2015;24(3):124-127.
27. Woolley KL, Ely JA, Woolley MJ, et al. Declaration of medical writing assistance in international peerreviewed publications. JAMA. 2006;296(8):932-934.
28. Flanagin A, Carey LA, Fontanarosa PB, et al. Prevalence of articles with honorary authors and ghost authors in peer-reviewed medical journals. JAMA. 1998;280(3):222-224.
29. Wislar JS, Flanagin A, Fontanarosa PB, DeAngelis CD. Honorary and ghost authorship in high impact biomedical journals: a cross sectional survey. BMJ. 2011;343:d6128. See also Web extra table 6125 and correction BMJ 2011;6343:d7677.